CS
RXDX

Credit Suisse’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Credit Suisse’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$2.04M Buy
2022
Q4 		$1.87M Buy
2022
Q3 		$535K Buy
2022
Q2 		$251K Sell
2022
Q1 		$417K Sell
2021
Q4 		$480K Buy